| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/27/1993 | WO1993003633A1 Process for obtaining a phenylalanine-free dietary product in pill or tablet form |
| 02/27/1993 | CA2094817A1 Process for obtaining a phenylalanine-free dietary product in pill or tablet form |
| 02/25/1993 | DE4218882A1 Saccharid in pulverform, verfahren zu dessen herstellung und dessen verwendung Saccharide in powder form, method for its preparation and its use |
| 02/24/1993 | EP0528777A2 Moisture permeable double disk |
| 02/24/1993 | EP0528776A1 Pharmaceutical composition containing carbachol and other cholinergic substances |
| 02/24/1993 | EP0528604A1 Melt cocrystallized sorbitol/xylitol compositions |
| 02/24/1993 | EP0528458A1 Method for controlling dental tartar using phosphopeptides and compositions for use therein |
| 02/24/1993 | EP0528313A1 Process for the preparation of a preserved medicine containing an human protein for injection of infusion |
| 02/24/1993 | EP0528303A1 Shaped bodies for the control of undesired organisms |
| 02/24/1993 | EP0527979A1 Pharmaceutical for treating viral diseases |
| 02/24/1993 | EP0527946A1 Controlled release vehicle. |
| 02/24/1993 | EP0527942A1 Colonic drug delivery system |
| 02/24/1993 | EP0527940A1 Direct spray-dried drug/lipid powder composition |
| 02/24/1993 | EP0527925A1 Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline |
| 02/24/1993 | EP0527891A1 Biodegradable polyesters for sustained drug delivery. |
| 02/24/1993 | EP0527810A1 Methods and compositions for reversibly permeabilizing the blood brain barrier |
| 02/24/1993 | EP0502949A4 Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same |
| 02/24/1993 | EP0393049B1 Liposomes preparation method and application of said liposomes as product vector |
| 02/24/1993 | CN1069196A Asparagus stem extract having anti-carcinoma activity |
| 02/24/1993 | CN1069191A Pharmaceutical combination formulation |
| 02/24/1993 | CN1069190A Traditional chinese medicine gum for preventing tooth diseases |
| 02/23/1993 | US5189148 Fibroblast growth factor; mixture with water insoluble hydroxypropyl cellulose |
| 02/23/1993 | US5189066 Antiinflammatory agent |
| 02/23/1993 | US5188951 Reacting phospholipid with primary alcohol in presence of enzyme catalyst in divalent cationic solution to form divalent salt, reacting formed salt with monovalent cationic salt to form monovalent salt |
| 02/23/1993 | US5188841 Sustained release pharmaceutical formulations |
| 02/23/1993 | US5188840 Slow-release pharmaceutical agent |
| 02/23/1993 | US5188839 Pharmaceutical compositions of cimetidine |
| 02/23/1993 | US5188838 Mixing melt with solidification promoting excipient, forcing through vibrating nozzle, allowing pearls to fall in tower countercurrently to gas |
| 02/23/1993 | US5188837 Water insoluble microparticles that have a layer of phospholipid embedding in surface |
| 02/23/1993 | US5188836 Release in both the stomach and small intestines; multilayer coating |
| 02/23/1993 | US5188835 Intravaginal devices |
| 02/23/1993 | US5188833 Antibacterial quinolinecarboxylic acid derivatives; photostability, heat resistance |
| 02/23/1993 | US5188826 Used for dry eye application, consists of crosslinked acrylic acid polymer, one or more demulcents and vasoconstrictors; administered to eye in drop or gel form and releases water |
| 02/23/1993 | US5188825 Freeze-dried dosage forms and methods for preparing the same |
| 02/23/1993 | US5188823 Antiperspirant formulations |
| 02/23/1993 | US5188817 Method of treatment for periodontitis |
| 02/23/1993 | CA2076558A1 Pharmaceutical compositions containing bradykinin antagonists for local use on the nose and eyes |
| 02/23/1993 | CA1313824C Transparent cosmetic composition reflecting infra-red rays made of titanium dioxyde flakes and its use for the protection of the humain skin against infra-red rays |
| 02/22/1993 | CA2076451A1 Instant water modifier |
| 02/22/1993 | CA2076316A1 Pesticidal shaped articles |
| 02/18/1993 | WO1993002712A1 Preparation of microparticles |
| 02/18/1993 | WO1993002709A1 Receptor conjugates for targeting drugs and other agents |
| 02/18/1993 | WO1993002699A1 Use of collagen for the treatment of degenerative joint ailments |
| 02/18/1993 | WO1993002695A1 Igf-1 to improve the neural condition |
| 02/18/1993 | WO1993002681A1 Prostaglandin-e1 formulation |
| 02/18/1993 | WO1993002669A1 Transdermal therapeutic systems |
| 02/18/1993 | WO1993002668A1 Microencapsulated quaternary ammonium compounds |
| 02/18/1993 | WO1993002667A1 Pharmaceutical composition |
| 02/18/1993 | WO1993002666A1 Self-stabilised multiphase emusion structures |
| 02/18/1993 | WO1993002665A1 W/o microemulsions |
| 02/18/1993 | WO1993002664A1 W/o microemulsions |
| 02/18/1993 | WO1993002663A1 Ophthalmic compositions based on polyhydric alcohols |
| 02/18/1993 | WO1993002662A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | WO1993002660A1 Emulsifier concentrates |
| 02/18/1993 | WO1993002653A1 Fluorocarbon blood substitute |
| 02/18/1993 | DE4127442A1 Aq. dispersion of phospholipid(s) contg. fluorocarbon(s) - used as gas transporting media in diagnoses, and as an oxygen@ transporting substance e.g. a component of artificial blood |
| 02/18/1993 | DE4126873A1 Parenterally administrable fluorocarbon emulsion as blood substitutes - contains phospholipid emulsifier, alkali fatty acid salt and distilled water |
| 02/18/1993 | DE4122591C1 Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants |
| 02/18/1993 | CA2114537A1 Transdermal therapeutic systems |
| 02/18/1993 | CA2114323A1 W/o microemulsions |
| 02/18/1993 | CA2114216A1 Antiviral pharmaceutical compositions for vaginal administration |
| 02/18/1993 | CA2114141A1 W/o microemulsions |
| 02/18/1993 | CA2113443A1 Prostaglandin e1 formulation |
| 02/17/1993 | EP0527638A1 Compositions comprising diltiazem in sustained release form and hydrochlorothiazide in immediate release form |
| 02/17/1993 | EP0527637A1 Spheroids containing dittiazem and a spheronizing agent |
| 02/17/1993 | EP0527241A1 The use of Ascorbic acid for the preparation of medicaments for use in the genital region |
| 02/17/1993 | EP0527196A1 Matrix system based on thermoplastic silicone copolymer |
| 02/17/1993 | EP0507768A4 Method and composition for treating xerostomia |
| 02/17/1993 | EP0452457A4 Method of in vivo delivery of functioning foreign genes |
| 02/17/1993 | CN1068965A Implant compositions containing biologically active protein, peptide or polypeptide |
| 02/17/1993 | CN1068961A Method of preparing stevia extract-containing liquid internal medicine |
| 02/17/1993 | CN1068960A Production process for capsular of chinese traditional medicine patent |
| 02/17/1993 | CN1068959A Encapsulated bioactive substances |
| 02/17/1993 | CN1068958A Processing method of leiwanfen injection |
| 02/16/1993 | US5187209 Storage stable protective colloids for use in medical diagnosis and/or therapy or as solid catalysts |
| 02/16/1993 | US5187150 Polyester-based composition for the controlled release of polypeptide medicinal substances |
| 02/16/1993 | US5186943 Compressed-molded preparations |
| 02/16/1993 | US5186942 Nicardipine therapy |
| 02/16/1993 | US5186941 Vesicle formulation for the controlled release of therapeutic agents |
| 02/16/1993 | US5186940 Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 02/16/1993 | US5186939 Laminated composite for transdermal administration of fentanyl |
| 02/16/1993 | US5186938 Crosslinked acrylic polymer as adhesive |
| 02/16/1993 | US5186937 Composition for feeding ruminants |
| 02/16/1993 | US5186936 Packing material for treatment of infections |
| 02/16/1993 | US5186930 Sustained release oral suspensions |
| 02/16/1993 | US5186925 Nitroglycerin pump spray |
| 02/16/1993 | US5186922 Injecting microspheres carrying nontoxic slow-dissolving radiation contrast agent into blood, radiation exposure, detection of defects |
| 02/16/1993 | US5186857 Oil in water liquid emulsions containing large amounts of oil or wax capable of being contained in a non-pressurized container without self-foaming, but which can be spread to self-develop a foam |
| 02/16/1993 | US5186717 Colorfastness, hair dyes |
| 02/16/1993 | CA1313623C Transdermal estrogen/progestin dosage unit, system and process |
| 02/16/1993 | CA1313620C Oral drug delivery systems |
| 02/16/1993 | CA1313617C Compositions for therapeutic percutaneous embolization and the use thereof |
| 02/13/1993 | CA2075356A1 Pharmaceutical spheroid formulation |
| 02/13/1993 | CA2075355A1 Pharmaceutical combination formulation |
| 02/11/1993 | DE4123292A1 Mundhygienemittel, verfahren zu ihrer herstellung und eine verwendung Oral hygiene composition, process for their preparation and use |
| 02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
| 02/10/1993 | EP0526865A1 Spongy material consisting essentially of hyaluronic acid or its derivatives, and its use in microsurgery |
| 02/10/1993 | EP0526862A1 Solid pharmaceutical compositions for oral administration with prolonged gastric residence |
| 02/10/1993 | EP0526756A1 Composition for revitalizing scar tissue |
| 02/10/1993 | EP0526700A2 Drug-containing protein-bonded liposome |